Association Between Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Outcomes Based on Race and Sex Among Patients With and Without Diabetes Mellitus: A Meta-Analysis of Nine Randomized Controlled Trials

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been shown to reduce major adverse cardiovascular events (MACEs) in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk. However, the efficacy of GLP-1 RAs on the outcomes of MACEs across...

Descripció completa

Dades bibliogràfiques

Autors principals:	Vikash Jaiswal, Yusra Mashkoor, Vamsikalyan Borra, Asmita Gera, Nirmit Patel, Sahas Reddy Jitta, Yusra Minahil Nasir, Prachi Sharma, Jishanth Mattumpuram
Format:	Artigo
Idioma:	Inglês
Publicat:	IMR Press 2026-01-01
Col·lecció:	Reviews in Cardiovascular Medicine
Matèries:	disparity race major adverse cardiovascular events glp-1 ras
Accés en línia:	https://www.imrpress.com/journal/RCM/27/1/10.31083/RCM45797
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!